z-logo
open-access-imgOpen Access
Melorheostosis and its treatment with intravenous zoledronic acid
Author(s) -
Rosemary Jane Hollick,
Alison J Black,
David M. Reid
Publication year - 2010
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr.04.2009.1757
Subject(s) - zoledronic acid , medicine , bisphosphonate , bone resorption , bone pain , surgery , biopsy , bone disease , osteoporosis , radiology
We report a case of melorheostosis, a rare bone disorder characterised by mesodermal dysplasia, and its successful and prolonged treatment with the intravenous bisphosphonate zoledronic acid. The middle-aged man presented with pain and swelling of his tibia, which was diagnosed by imaging and bone biopsy as being due to melorheostosis. There was early symptom control after a single infusion of intravenous zoledronic acid. Prolonged symptom relief was accompanied by long-term suppression of the bone resorption marker β cross-laps. We suggest that melorheostosis can be treated with intravenous zoledronic acid and that treatment can be monitored by the use of a specific bone resorption marker.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here